APA

Raizer J. J., Giglio P., Hu J., Groves M., Merrell R., Conrad C., Phuphanich S., Puduvalli V. K., Loghin M., Paleologos N., Yuan Y., Liu D., Rademaker A., Yung W. K., Vaillant B., Rudnick J., Chamberlain M., Vick N., Grimm S., Tremont-Lukats I. W., De Groot J., Aldape K. & Gilbert M. R. (20160928). A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. : Journal of neuro-oncology.

Chicago

Raizer J J, Giglio P, Hu J, Groves M, Merrell R, Conrad C, Phuphanich S, Puduvalli V K, Loghin M, Paleologos N, Yuan Y, Liu D, Rademaker A, Yung W K, Vaillant B, Rudnick J, Chamberlain M, Vick N, Grimm S, Tremont-Lukats I W, De Groot J, Aldape K and Gilbert M R. 20160928. A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. : Journal of neuro-oncology.

Harvard

Raizer J. J., Giglio P., Hu J., Groves M., Merrell R., Conrad C., Phuphanich S., Puduvalli V. K., Loghin M., Paleologos N., Yuan Y., Liu D., Rademaker A., Yung W. K., Vaillant B., Rudnick J., Chamberlain M., Vick N., Grimm S., Tremont-Lukats I. W., De Groot J., Aldape K. and Gilbert M. R. (20160928). A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. : Journal of neuro-oncology.

MLA

Raizer J J, Giglio P, Hu J, Groves M, Merrell R, Conrad C, Phuphanich S, Puduvalli V K, Loghin M, Paleologos N, Yuan Y, Liu D, Rademaker A, Yung W K, Vaillant B, Rudnick J, Chamberlain M, Vick N, Grimm S, Tremont-Lukats I W, De Groot J, Aldape K and Gilbert M R. A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. : Journal of neuro-oncology. 20160928.